Why the study?
Does clinicopathologic subclassification of malignant fibrous histiocytomas provide prognostic information?
Does clinicopathologic subclassification of malignant fibrous histiocytomas provide prognostic information?
Subclassification of malignant fibrous histiocytomas is clinically important, as pleomorphic soft tissue sarcomas with myogenic differentiation are significantly more aggressive.
Answers are grounded in this paper and cite their sources.
May support prognostic subclassification in pleomorphic sarcomas; leaves open impact on therapy.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Fletcher et al. (2001) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: